Clinical research studyPatient Education Program for Venous Thromboembolism Prevention in Hospitalized Patients
Section snippets
Patient Population
Brigham and Women's Hospital is a 793-bed acute tertiary care facility providing medical and surgical care for patients with general medical, cardiothoracic, orthopedic, oncologic, neurologic, obstetric and gynecologic, neonatal, urologic, and gastrointestinal conditions. Brigham and Women's Hospital utilizes a Medical Informatics System that integrates an online medical record, computerized provider order entry, and an electronic medication administration record.
Identification of Study Subjects
Using our event-based rules
Baseline Demographics and Clinical Characteristics
Patient education sessions were conducted for all 528 hospitalized patients enrolled in the study. Subjects enrolled in the patient education program had a median age of 58 years and a median venous thromboembolism risk score of 3 (Table 1). The median length of stay was 4 days.
Pharmacological Venous Thromboembolism Prophylaxis
Subcutaneously administered unfractionated heparin (54.9%) was the most frequently prescribed form of pharmacological venous thromboembolism prophylaxis followed by subcutaneously administered dalteparin (44.7%) (Table 2
Discussion
We found that a pharmacist-led individualized patient education program resulted in significantly higher medication adherence to clinician-ordered injectable pharmacological venous thromboembolism prophylaxis than in our historical cohort. The patient education program was associated with a one-third lower frequency of patient refusal as a reason for omitted doses of clinician-ordered injectable prophylactic anticoagulation. We found that the pharmacist-led patient education program was
References (25)
- et al.
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th Edition)
Chest
(2008) - et al.
Thromboprophylaxis rates in US medical centers: success or failure?
J Thromb Haemost
(2007) - et al.
Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada
Thromb Res
(2007) - et al.
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
Lancet
(2008) - et al.
Improving clinical effectiveness in thromboprophylaxis for hospitalized medical patients
Am J Med
(2009) - et al.
Adherence to pharmacological thromboprophylaxis orders in hospitalized patients
Am J Med
(2010) The surgeon general's call to action to prevent deep vein thrombosis and pulmonary embolism
(2008)- et al.
Venous thromboembolic events in hospitalised medical patients
Thromb Haemost
(2009) - et al.
Long-term complications of medical patients with hospital-acquired venous thromboembolism
Thromb Haemost
(2009) Prevention and treatment of venous thromboembolismInternational Consensus Statement (guidelines according to scientific evidence)
Int Angiol
(2006)
Electronic alerts to prevent venous thromboembolism among hospitalized patients
N Engl J Med
Multi-screen electronic alerts to augment venous thromboembolism prophylaxis
Thromb Haemost
Cited by (35)
Implementation of the standardized process of Pharmacotherapeutic evaluation in inpatients and outpatients
2023, Farmacia HospitalariaEffectiveness of a Patient Education Bundle on Venous Thromboembolism Prophylaxis Administration by Sex
2022, Journal of Surgical ResearchCitation Excerpt :Moreover, the effect size was similar for both male and female patients, which we hypothesized, would be the case because the patient-centered education bundle was developed with a diverse stakeholder population which was well represented by male and female patients. More effective communication of health information patients can easily understand has been shown to benefit this particular area of care.12,14,16-18 Therefore, a patient-specific strategy for VTE prophylaxis education is crucial.12,14
Effect of an interactive, educational app about venous thromboembolism and anticoagulation on patient satisfaction: A randomized controlled trial
2022, Thrombosis ResearchCitation Excerpt :This may have left less room for improvement. Although several educational interventions on primary thromboprophylaxis have been developed and studied [22–24], literature on patient education after a first VTE is scarce [11,25]. Additional education on top of standard of care for patients treated with anticoagulation has been shown to improve knowledge and reduce number of thromboembolic, bleeding events and mortality in a meta-analysis [25].
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative
2020, American Journal of MedicineCitation Excerpt :Provider-related barriers include a lack of awareness of VTE risk, complex practice recommendations, concerns about bleeding, and failure to use evidence-based guidelines.74 Patient-related factors include refusal of VTE prophylaxis76-79 and a general lack of knowledge about VTE.80 Aggregate data from prior studies suggest that a multidisciplinary team approach, continuous collaboration with stakeholders at all levels (ie, institutional leaders, experts, physicians, nurses, pharmacists, and patients), and combined patient- and provider-facing strategies are the most effective ways to implement successful practices.
Please stop using venous thromboembolism (VTE) outcomes for Pay-for-Performance and Public reporting
2019, Joint Commission Journal on Quality and Patient Safety
Funding: This study was funded, in part, by an unrestricted clinical research grant from sanofi-aventis. Dr Goldhaber (Principal Investigator), Thanh Nha Nguyen (research pharmacist), and Ruth Morrison (research nurse) were partially compensated with these funds. Dr Piazza is supported by a Research Career Development Award (K12 HL083786) from the National Heart, Lung, and Blood Institute (NHLBI).
Conflict of Interest: Dr Goldhaber receives clinical research grant support from sanofi-aventis. None of the other authors have any conflicts of interest to disclose.
Authorship: All of the authors had access to the data and participated in the writing of the manuscript.